Many beauty shows across the UK are guilty of offering members of the public injectable cosmetic fillers. In a bid to put a halt to this unethical practice, the Safety In Beauty Campaign is pledging to spearhead a ban on the practice at as many beauty shows possible around the UK.

The first successful outcome of this campaign led to injectable cosmetic treatments being banned from The Anti-Ageing Show, held earlier this month at Olympia in London. The Safety in Beauty Campaign worked closely with the show organisers, CRS Media, and it was mutually agreed that carrying out cosmetic injections on consumers in a public event setting was neither ethical, nor clinically appropriate.

‘We are delighted and proud to be the first consumer exhibition and consumer event to ban cosmetic injectable treatments being offered and sold at a public event,’ said Shelley Williams, Director of CRS Media and Organiser of The Anti-Ageing Show.

‘We are huge supporters of Safety In Beauty and feel that our event can lead by example. Consumers looking for cut-price bargains need to be educated and informed to make decisions that are not price-led. Our event is held to help consumers navigate safely through the wealth of options available in the beauty, anti-ageing and cosmetic interventions industry, and our decision to ban injectable treatments being sold on exhibitors stands upholds our stance towards consumer safety.’

In the first year of The Anti-Ageing Show, two stand exhibitors offered injectable treatments to members of the public, but in light of the Keogh Review and a growing concern for consumer safety, the Safety In Beauty campaign has pledged to work as closely as possible with national show and exhibition organisers to ban the practice of needle treatments at consumer shows.

The Campaign’s Founder, Antonia Mariconda, is now speaking to the organisers of other well-known beauty shows in an attempt to try and ban cosmetic injections being offered.

‘It is highly inappropriate and unethical to offer cut-price injectable cosmetic interventions to members of the public at large-scale consumer events,’ said Mariconda. ‘Not only is this an aggressive, commercially-driven sales tactic to a consumer, but it also poses health and safety risks, as carrying out cosmetic treatments via needles in a setting which is not sterile or clinical poses huge risks. For these reasons, Safety In Beauty believes that such interventions should be confined to clinical environments where consumers have a professional consultation with a reputable qualified professional and have sufficient time, with no sales pressure to make a decision.’